Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.17
$0.087.34%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.14% | -7.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.14% | -7.17% | |||
| Cost of Revenue | 9.06% | -6.55% | |||
| Gross Profit | 12.37% | -7.53% | |||
| SG&A Expenses | 13.86% | -14.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -2,331.81% | 90.77% | |||
| Total Operating Expenses | 10.80% | -8.99% | |||
| Operating Income | 12.35% | 0.01% | |||
| Income Before Tax | -16.84% | 15.03% | |||
| Income Tax Expenses | 4.42% | 15.79% | |||
| Earnings from Continuing Operations | -25.47% | 14.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.47% | 14.72% | |||
| EBIT | 12.35% | 0.01% | |||
| EBITDA | 11.16% | -2.41% | |||
| EPS Basic | -26.00% | 15.74% | |||
| Normalized Basic EPS | -17.35% | 17.74% | |||
| EPS Diluted | -26.00% | 15.74% | |||
| Normalized Diluted EPS | -17.35% | 17.74% | |||
| Average Basic Shares Outstanding | 0.83% | -0.87% | |||
| Average Diluted Shares Outstanding | 0.83% | -0.87% | |||
| Dividend Per Share | -- | -67.22% | |||
| Payout Ratio | -1.00% | -0.09% | |||